STOCK TITAN

[Form 4] Know Labs, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Know Labs, Inc. (KNW) reporting person Peter J. Conley, identified as a former Chief Financial Officer, acquired 107,500 shares of Common Stock on 07/31/2025 at a reported price of $0. After the transaction he beneficially owned 157,750 shares, held indirectly through Prestwick Associates LLC. The Form 4 discloses this insider acquisition and the form of ownership.

Know Labs, Inc. (KNW) — la persona segnalante Peter J. Conley, indicata come ex Chief Financial Officer, ha acquisito 107.500 azioni ordinarie in data 31/07/2025 al prezzo dichiarato di $0. Dopo l'operazione deteneva a titolo beneficiario 157.750 azioni, detenute in via indiretta tramite Prestwick Associates LLC. Il Modulo 4 rende nota questa acquisizione da parte di un insider e la relativa forma di proprietà.

Know Labs, Inc. (KNW) — la persona informante Peter J. Conley, identificado como ex director financiero (CFO), adquirió 107.500 acciones ordinarias el 31/07/2025 a un precio declarado de $0. Tras la operación poseía a título beneficiario 157.750 acciones, mantenidas de forma indirecta a través de Prestwick Associates LLC. El Formulario 4 divulga esta adquisición por parte de un insider y la modalidad de titularidad.

Know Labs, Inc. (KNW) 보고인인 Peter J. Conley는 전 최고재무책임자(CFO)로 확인되며, 2025년 7월 31일에 보통주 107,500주를 신고된 가격 $0에 취득했습니다. 거래 후 그는 수익적 보유자로서 157,750주를 보유했으며, 이는 Prestwick Associates LLC를 통한 간접 보유입니다. 해당 내용은 Form 4에 이 내부자 취득 및 소유 형태로 공개되어 있습니다.

Know Labs, Inc. (KNW) — la personne déclarante Peter J. Conley, identifiée comme ancien directeur financier (CFO), a acquis 107 500 actions ordinaires le 31/07/2025 au prix déclaré de $0. Après l'opération, il détenait à titre bénéficiaire 157 750 actions, détenues indirectement via Prestwick Associates LLC. Le formulaire 4 divulgue cette acquisition par un initié ainsi que la forme de détention.

Know Labs, Inc. (KNW) — die meldende Person Peter J. Conley, ausgewiesen als ehemaliger Chief Financial Officer, erwarb am 31.07.2025 107.500 Stammaktien zum gemeldeten Preis von $0. Nach der Transaktion hielt er wirtschaftlich 157.750 Aktien, die indirekt über Prestwick Associates LLC gehalten werden. Das Formular 4 macht diese Insider-Erwerbung und die Form des Eigentums öffentlich.

Positive
  • Insider acquisition: Peter J. Conley acquired 107,500 shares of Know Labs common stock.
  • Increased beneficial ownership: Total beneficial ownership reported as 157,750 shares indirectly via Prestwick Associates LLC.
Negative
  • None.

Insights

TL;DR: Insider acquired 107,500 KNW shares, raising indirect holdings to 157,750.

The Form 4 shows Peter J. Conley acquired 107,500 common shares on 07/31/2025 at a reported price of $0 and now beneficially owns 157,750 shares indirectly via Prestwick Associates LLC. This filing documents an insider purchase and the resulting indirect ownership level; the filing does not provide market context, transaction rationale, or valuation details.

TL;DR: Former CFO reports an indirect increase in ownership via Prestwick Associates LLC.

The reporting person is identified as a former Chief Financial Officer and disclosed an acquisition of 107,500 shares and indirect beneficial ownership of 157,750 shares through Prestwick Associates LLC. The Form 4 explicitly notes the ownership form and nature of indirect ownership; it does not include any contractual plan, amendment details, or explanatory narrative.

Know Labs, Inc. (KNW) — la persona segnalante Peter J. Conley, indicata come ex Chief Financial Officer, ha acquisito 107.500 azioni ordinarie in data 31/07/2025 al prezzo dichiarato di $0. Dopo l'operazione deteneva a titolo beneficiario 157.750 azioni, detenute in via indiretta tramite Prestwick Associates LLC. Il Modulo 4 rende nota questa acquisizione da parte di un insider e la relativa forma di proprietà.

Know Labs, Inc. (KNW) — la persona informante Peter J. Conley, identificado como ex director financiero (CFO), adquirió 107.500 acciones ordinarias el 31/07/2025 a un precio declarado de $0. Tras la operación poseía a título beneficiario 157.750 acciones, mantenidas de forma indirecta a través de Prestwick Associates LLC. El Formulario 4 divulga esta adquisición por parte de un insider y la modalidad de titularidad.

Know Labs, Inc. (KNW) 보고인인 Peter J. Conley는 전 최고재무책임자(CFO)로 확인되며, 2025년 7월 31일에 보통주 107,500주를 신고된 가격 $0에 취득했습니다. 거래 후 그는 수익적 보유자로서 157,750주를 보유했으며, 이는 Prestwick Associates LLC를 통한 간접 보유입니다. 해당 내용은 Form 4에 이 내부자 취득 및 소유 형태로 공개되어 있습니다.

Know Labs, Inc. (KNW) — la personne déclarante Peter J. Conley, identifiée comme ancien directeur financier (CFO), a acquis 107 500 actions ordinaires le 31/07/2025 au prix déclaré de $0. Après l'opération, il détenait à titre bénéficiaire 157 750 actions, détenues indirectement via Prestwick Associates LLC. Le formulaire 4 divulgue cette acquisition par un initié ainsi que la forme de détention.

Know Labs, Inc. (KNW) — die meldende Person Peter J. Conley, ausgewiesen als ehemaliger Chief Financial Officer, erwarb am 31.07.2025 107.500 Stammaktien zum gemeldeten Preis von $0. Nach der Transaktion hielt er wirtschaftlich 157.750 Aktien, die indirekt über Prestwick Associates LLC gehalten werden. Das Formular 4 macht diese Insider-Erwerbung und die Form des Eigentums öffentlich.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Conley Peter J

(Last) (First) (Middle)
619 WESTERN AVENUE
SUITE 610

(Street)
SEATTLE WA 98104

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KNOW LABS, INC. [ KNW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
Former Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/31/2025 A 107,500 A $0 157,750 I Prestwick Associates LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Peter J. Conley 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for Know Labs (KNW) report?

The Form 4 reports that Peter J. Conley acquired 107,500 shares of common stock on 07/31/2025 and beneficially owns 157,750 shares indirectly.

At what price were the KNW shares acquired by the reporting person?

The filing shows a reported price of $0 for the acquisition recorded on the Form 4.

How is the ownership held according to the Form 4 for KNW?

The filing indicates the beneficial ownership is held indirectly via Prestwick Associates LLC.

What is the reporting person’s relationship to Know Labs (KNW)?

The Form 4 identifies the reporting person, Peter J. Conley, as a former Chief Financial Officer of the issuer.

Does the Form 4 explain the reason for the transaction?

No. The Form 4 discloses the transaction details and ownership form but does not provide an explanation or rationale for the acquisition.
Know Labs

NYSE:KNW

KNW Rankings

KNW Latest News

KNW Latest SEC Filings

KNW Stock Data

18.37M
6.57M
12.43%
2.18%
9.25%
Scientific & Technical Instruments
Measuring & Controlling Devices, Nec
Link
United States
SEATTLE